Using eye tracking to detect autism risk in young children
Use of Eye Tracking to Aid in Autism Risk Detection
This study is testing if a special eye-tracking device can help find signs of autism risk in young children aged 12 to 48 months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 12 Months to 48 Months |
| Sex | All |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT06471504 on ClinicalTrials.gov |
What this trial studies
This study employs a non-invasive remote eye-tracking system called Eyelink Portable Duo to gather eye-tracking data from young children aged 12 to 48 months. The measures collected, which include looking time, pupil diameter, and oculomotor dynamics, aim to identify potential indicators of autism risk. Conducted at Riley Hospital for Children at Indiana University Health, the study seeks to determine the effectiveness of these eye-tracking metrics in assessing autism risk in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates for this study are young children aged 12 to 48 months who are scheduled for healthcare visits at Riley Hospital for Children and have English- or Spanish-speaking caregivers.
Not a fit: Children outside the age range of 12 to 48 months or whose caregivers do not speak English or Spanish may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate detection of autism risk in young children.
How similar studies have performed: While the use of eye tracking in autism detection is a growing field, this specific approach is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young children ages 12-48 months scheduled for health care visits at Riley Hospital for Children at Indiana University Health clinics (e.g., Pediatric Care Center clinics). * Children must have English- or Spanish-speaking caregivers. * Children must have a legal guardian that is able to provide consent. Exclusion Criteria: * Child is younger than 12 months or older than 48 months. * Child's caregiver(s) is not English- or Spanish-speaking.
Where this trial is running
Indianapolis, Indiana
- Riley Hospital for Children — Indianapolis, Indiana, United States (Recruiting)
Study contacts
- Principal investigator: Rebecca R McNally Keehn, PhD, HSPP — IU School of Medicine
- Study coordinator: Rebecca McNally Keehn, PhD, HSPP
- Email: mcnallyr@iu.edu
- Phone: 317-278-3435
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.